| Structure of the human glucagon class B G-protein-coupled receptor FY Siu, M He, C De Graaf, GW Han, D Yang, Z Zhang, C Zhou, Q Xu, ... Nature 499 (7459), 444-449, 2013 | 456 | 2013 |
| Common activation mechanism of class A GPCRs Q Zhou, D Yang, M Wu, Y Guo, W Guo, L Zhong, X Cai, A Dai, W Jang, ... Elife 8, e50279, 2019 | 397 | 2019 |
| G protein-coupled receptors: structure-and function-based drug discovery D Yang, Q Zhou, V Labroska, S Qin, S Darbalaei, Y Wu, E Yuliantie, L Xie, ... Signal transduction and targeted therapy 6 (1), 7, 2021 | 324 | 2021 |
| Glucagon-like peptide-1 and its class BG protein–coupled receptors: a long march to therapeutic successes C De Graaf, D Donnelly, D Wootten, J Lau, PM Sexton, LJ Miller, JM Ahn, ... Pharmacological reviews 68 (4), 954-1013, 2016 | 303 | 2016 |
| Phase-plate cryo-EM structure of a biased agonist-bound human GLP-1 receptor–Gs complex YL Liang, M Khoshouei, A Glukhova, SGB Furness, P Zhao, L Clydesdale, ... Nature 555 (7694), 121-125, 2018 | 298 | 2018 |
| Insights into the structure of class B GPCRs K Hollenstein, C de Graaf, A Bortolato, MW Wang, FH Marshall, ... Trends in Pharmacological Sciences 35 (1), 12-22, 2014 | 265 | 2014 |
| Development and application of rodent models for type 2 diabetes D Chen, MW Wang Diabetes, Obesity and Metabolism 7 (4), 307-317, 2005 | 262 | 2005 |
| Human GLP-1 receptor transmembrane domain structure in complex with allosteric modulators G Song, D Yang, Y Wang, C De Graaf, Q Zhou, S Jiang, K Liu, X Cai, ... Nature 546 (7657), 312-315, 2017 | 224 | 2017 |
| A nonpeptidic agonist of glucagon-like peptide 1 receptors with efficacy in diabetic db/db mice D Chen, J Liao, N Li, C Zhou, Q Liu, G Wang, R Zhang, S Zhang, L Lin, ... Proceedings of the National Academy of Sciences 104 (3), 943-948, 2007 | 220 | 2007 |
| Structure of the full-length glucagon class B G-protein-coupled receptor H Zhang, A Qiao, D Yang, L Yang, A Dai, C De Graaf, S Reedtz-Runge, ... Nature 546 (7657), 259-264, 2017 | 200 | 2017 |
| Structure and dynamics of the active human parathyroid hormone receptor-1 LH Zhao, S Ma, I Sutkeviciute, DD Shen, XE Zhou, PW de Waal, CY Li, ... Science 364 (6436), 148-153, 2019 | 194 | 2019 |
| Neutrophil-derived cathelicidin promotes adhesion of classical monocytes S Wantha, JE Alard, RTA Megens, AM van der Does, Y Döring, ... Circulation Research 112 (5), 792-801, 2013 | 181 | 2013 |
| Bioactive compounds from peperomia pellucida S Xu, N Li, MM Ning, CH Zhou, QR Yang, MW Wang Journal of Natural Products 69 (2), 247-250, 2006 | 169 | 2006 |
| Transcriptional and proteomic insights into the host response in fatal COVID-19 cases M Wu, Y Chen, H Xia, C Wang, CY Tan, X Cai, Y Liu, F Ji, P Xiong, R Liu, ... Proceedings of the National Academy of Sciences 117 (45), 28336-28343, 2020 | 153 | 2020 |
| Botanical drugs: challenges and opportunities: contribution to Linnaeus Memorial Symposium 2007 Y Liu, MW Wang Life Sciences 82 (9), 445-449, 2008 | 150 | 2008 |
| Biological screening of natural products and drug innovation in China MW Wang, X Hao, K Chen Philosophical Transactions of the Royal Society B: Biological Sciences 362 …, 2007 | 144 | 2007 |
| Extending the structural view of class B GPCRs C de Graaf, G Song, C Cao, Q Zhao, MW Wang, B Wu, RC Stevens Trends in biochemical sciences 42 (12), 946-960, 2017 | 134 | 2017 |
| The role of Tanshinone IIA in the treatment of obesity through peroxisome proliferator-activated receptor γ antagonism Z Gong, C Huang, X Sheng, Y Zhang, Q Li, MW Wang, L Peng, YQ Zang Endocrinology 150 (1), 104-113, 2009 | 133 | 2009 |
| Activation of the GLP-1 receptor by a non-peptidic agonist P Zhao, YL Liang, MJ Belousoff, G Deganutti, MM Fletcher, FS Willard, ... Nature 577 (7790), 432-436, 2020 | 131 | 2020 |
| Innovation in neglected tropical disease drug discovery and development HB Weng, HX Chen, MW Wang Infectious diseases of poverty 7 (03), 1-9, 2018 | 127 | 2018 |
